New Alzheimer’s Protocol Seeks to Slow Progression, Even Reverse Disease
Epigenesis Corporation announces its new BEEMS Protocol for the treatment of Alzheimer's disease. This proprietary, groundbreaking new mitigation protocol seeks to disrupt and delay the progress of the disease and provide potential solutions for sufferers around the world, long before they become too debilitated to function.